USPTO serial 79249068
SANOFI GENZYME
Reviewed by CopyMark Law Group
Reg. 5986713Status 709
- Filing date
- Status date
- Registration date
- Feb 18, 2020
- Examiner
- CAYCEDO, CATHERINE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SANOFI GENZYME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42nd St., 17 Fl.NEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceutical and cosmetic substances and preparations; full line of enzymes for laboratory diagnosis and enzymes for industrial use, not for medical purposes | SECTION 71 - CANCELLED | — |
| 003 | Non-medicinal cosmetic preparations for hygiene, skin care and care; cosmetic preparations | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and medicinal preparations for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; sanitary preparations for medical purposes; dietetic food and beverage substances adapted for medical use; pharmaceutical preparation for use as replacement enzyme and for the prevention of adhesion during medical surgeries; reagents for medical diagnosis; chemical preparations for medical and pharmaceutical use, namely, for the treatment of cardiovascular diseases and diseases of the central nervous system, cancer, thrombosis, respiratory diseases, lysosomal storage diseases, rare blood disorders, and for the prevention and treatment of infectious diseases, namely, viral and bacterial infections, sold on prescription or over the counter; vaccines; nutritional supplements; plant extracts for pharmaceutical purposes; pharmacological preparations for skin care | SECTION 71 - CANCELLED | — |
| 009 | Software relating to health, namely, downloadable computer software for database management in the field of pharmaceutical and medical developments, downloadable software accessible via the internet or mobile phone applications for monitoring and tracking blood glucose levels, downloadable mobile software in the nature of interactive games in the field of healthcare; CD-ROMs featuring information about health; medical imaging software | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments, namely, blood glucose monitors, blood glucose monitor kits comprising blood glucose monitors, lancets and control solutions, insulin injectors sold empty, asthma inhalers for medical and therapeutic use sold empty; surgical apparatus and instruments; apparatus for imaging and X-Ray apparatus for medical use; inhalers for therapeutic use sold empty and parts and fittings therefor; devices for the injection of medicines, namely, pens for injection | SECTION 71 - CANCELLED | — |
| 016 | Printed matter, namely, bulletins, magazines, periodicals, books, journals, and posters, all in the field of health | SECTION 71 - CANCELLED | — |
| 035 | Advice in business, namely, business management advice; advice services, namely, provision of commercial information to the consumer regarding products; advertising and marketing services; distribution services, namely, distribution of products and information on pharmaceutical products for advertising purposes; business administration and management of business affairs in the field of health; promoting public awareness regarding healthcare via printed material | SECTION 71 - CANCELLED | — |
| 038 | Telecommunication services, namely, transmission of information by telephone, television, and by computer terminals via Internet sites in the field of health; transmission of information for others relating to health, communication of information for patients or health professionals via computers, via the Internet, television and radio; provision of online chat rooms and online forums for transmission of messages among Internet users concerning health care, medicines and pharmaceutical and medical developments | SECTION 71 - CANCELLED | — |
| 040 | Custom manufacture of products relating to health, namely, pharmaceuticals and medicines by pharmaceutical compounders | SECTION 71 - CANCELLED | — |
| 041 | Education and training relating to health, namely, arranging seminars, conferences and congresses in the field of health care; publication of magazines, books and guides; training relating to health using electronic and digital tools, namely, providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of health care | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research in the fields of chemistry, biology and pharmacy, creation and development of software and databases, clinical studies in the nature of chemistry, biology and pharmacy laboratory research in the field of health, engineering services relating to research and development of enzymes and genetics | SECTION 71 - CANCELLED | — |
| 044 | Consultancy in the field of pharmaceuticals and healthcare; provision of medical information and information relating to health via awareness campaigns | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SANOFI
- Other trademarks owned by SANOFI
- Other trademarks owned by SANOFI
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SANOFI GENZYME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | C71T | CANCELLED SECTION 71 | — |
| Feb 18, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 17, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 6, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 6, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 18, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 18, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 8, 2020 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Dec 27, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 11, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2019 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 22, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 1, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 1, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 19, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 18, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 3, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |